Nath Bio-Genes (India) Limited has announced its unaudited financial results for the period ended December 31, 2025 (Q3 FY26). The company reported a significant 79% year-on-year increase in total revenue, reaching ₹660 million (₹66 crore) for the third quarter. Gross Profit saw a 51% YoY rise to ₹369 million (₹36.9 crore), while EBITDA increased by 18% YoY to ₹88 million (₹8.8 crore). Profits from Ordinary Business, excluding extraordinary items, grew by 67% YoY to ₹45 million (₹4.5 crore). Earnings Per Share (EPS) also showed substantial growth, increasing by 171% YoY to ₹3.8. For the nine-month period ended December 31, 2025 (9MFY26), total revenue grew by 23% YoY to ₹3,859 million (₹385.9 crore). Gross Profit increased by 26% YoY to ₹2,075 million (₹207.5 crore), and EBITDA stood at ₹499 million (₹49.9 crore), a marginal decrease of 2% YoY. Profits from Ordinary Business (excluding extraordinary items) for 9MFY26 were ₹399 million (₹39.9 crore), a 1% increase YoY. The EPS for 9MFY26 was ₹23.49, up 13% YoY. The company highlighted strong performance across its crop segments. Cotton (Bt) reported a 21.35% YoY rise in quantity and a 25.26% value growth. Paddy showed a 7.75% YoY growth in quantity and an 18.60% value increase. Maize achieved exceptional 94.77% YoY growth in quantity, with a 141.98% surge in value. Vegetable Seeds delivered robust 43.44% YoY growth in quantity and a 52.08% value increase. PNS reported a marginal volume decline but a steady value increase of 1.20%. Nath Bio-Genes also noted the successful operation of its Uzbekistan joint venture, strengthening its international presence. The company's strategic focus remains on driving diversification beyond cotton, accelerating growth in high-margin products, enhancing operational efficiency, and strengthening innovation through focused R&D.
